Lim DW - Search Results

1

Dietary factors and the risk of lung cancer by epidermal growth factor receptor mutation status and histological subtypes.

Yin X, Lai GGY, Seow A, Tan DSW, Lim DW, Seow WJ. Yin X, et al. Among authors: lim dw. Front Public Health. 2022 Dec 2;10:1079543. doi: 10.3389/fpubh.2022.1079543. eCollection 2022. Front Public Health. 2022. PMID: 36530673 Free PMC article.

2

Advances in systemic treatment for nasopharyngeal carcinoma.

Tan WL, Tan EH, Lim DW, Ng QS, Tan DS, Jain A, Ang MK. Tan WL, et al. Among authors: lim dw. Chin Clin Oncol. 2016 Apr;5(2):21. doi: 10.21037/cco.2016.03.03. Chin Clin Oncol. 2016. PMID: 27121881 Free article. Review.

3

Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).

Fong PY, Tan SH, Lim DWT, Tan EH, Ng QS, Sommat K, Tan DSW, Ang MK. Fong PY, et al. PLoS One. 2019 Nov 20;14(11):e0224665. doi: 10.1371/journal.pone.0224665. eCollection 2019. PLoS One. 2019. PMID: 31747406 Free PMC article.

4

Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma.

Lim DW, Kao HF, Suteja L, Li CH, Quah HS, Tan DS, Tan SH, Tan EH, Tan WL, Lee JN, Wee FY, Jain A, Goh BC, Chua MLK, Liao BC, Ng QS, Hong RL, Ang MK, Yeong JP, Iyer NG. Lim DW, et al. Nat Commun. 2023 May 15;14(1):2781. doi: 10.1038/s41467-023-38407-7. Nat Commun. 2023. PMID: 37188668 Free PMC article.

5

Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR+ non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance.

Ma J, Tan SH, Yin DXC, Tran NTA, Tan GS, Lai GGY, Ang MK, Kanesvaran R, Jain A, Rajasekaran T, Tan EH, Lim TKH, Tan DS, Lim DW, Ng QS, Tan WL. Ma J, et al. Among authors: lim dw, lim tkh. Transl Lung Cancer Res. 2023 Apr 28;12(4):742-753. doi: 10.21037/tlcr-22-661. Epub 2023 Mar 15. Transl Lung Cancer Res. 2023. PMID: 37197627 Free PMC article.

6

Combinatorial Hypofractionated Radiotherapy and Pembrolizumab in Anaplastic Thyroid Cancer.

Tan JSH, Tay TKY, Ong EHW, Fehlings M, Tan DS, Sukma NB, Chen EX, Sng JH, Yip CSP, Lim KH, Lim DW, Iyer NG, Hwang JSG, Chua MLK, Ang MK. Tan JSH, et al. Among authors: lim dw, lim kh. Eur Thyroid J. 2024 Jan 1;13(1):e230144. doi: 10.1530/ETJ-23-0144. Online ahead of print. Eur Thyroid J. 2024. PMID: 38181007 Free PMC article.

7

Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases.

Tan WL, Ng QS, Lim C, Tan EH, Toh CK, Ang MK, Kanesvaran R, Jain A, Tan DSW, Lim DW. Tan WL, et al. Among authors: lim c, lim dw. BMC Cancer. 2018 Dec 3;18(1):1198. doi: 10.1186/s12885-018-5110-2. BMC Cancer. 2018. PMID: 30509246 Free PMC article.

8

The case for better hospitalisation selection in cancer patients.

Lim DWT, Ng QS. Lim DWT, et al. Ann Acad Med Singap. 2021 Dec;50(12):880-881. doi: 10.47102/annals-acadmedsg.2021451. Ann Acad Med Singap. 2021. PMID: 34985099 Free article. No abstract available.

9

Is There a Unicorn Among the Uncommon EGFR Mutations?

Tan WL, Lim DW. Tan WL, et al. Among authors: lim dw. J Thorac Oncol. 2023 Feb;18(2):129-132. doi: 10.1016/j.jtho.2022.11.009. J Thorac Oncol. 2023. PMID: 36682837 Free article. No abstract available.

10

Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.

Lee NY, Hum M, Zihara S, Wang L, Myint MK, Lim DW, Toh CK, Skanderup A, Samol J, Tan MH, Ang P, Lee SC, Tan EH, Lai GGY, Tan DSW, Yap YS, Lee ASG. Lee NY, et al. Among authors: lim dw. Hum Genomics. 2023 Jul 17;17(1):66. doi: 10.1186/s40246-023-00510-7. Hum Genomics. 2023. PMID: 37461096 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters